FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line.

This publication has 23 references indexed in Scilit:

• Physical interaction of the retinoblastoma protein with human D cyclins
  Cell, 1993
• Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression
  Cell, 1993
• Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
  Cell, 1992
• D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA
  Cell, 1992
• Formation and Activation of a Cyclin E-cdk2 Complex During the G ₁ Phase of the Human Cell Cycle
  Science, 1992
• Rapamycin-Induced Inhibition of the 70-Kilodalton S6 Protein Kinase
  Science, 1992
• Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase
  Nature, 1992
• Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases
  Cell, 1992
• Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
  Science, 1991
• Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
  Proceedings of the National Academy of Sciences, 1990